{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:58:27Z","timestamp":1793321907554,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405160"],"award-info":[{"award-number":["82405160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phymed.2026.158584","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:59:45Z","timestamp":1784044785000},"page":"158584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dihydroartemisinin promotes ABCG5\/G8-mediated cholesterol efflux to potentiate anti-PD-1 therapy through YAP1-TEAD1 complex disruption in hepatocellular carcinoma"],"prefix":"10.1016","volume":"159","author":[{"given":"Yuting","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-1156","authenticated-orcid":false,"given":"Xinli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12072-020-10120-3","article-title":"Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis","volume":"15","author":"Blanc","year":"2021","journal-title":"Hepatol. Int."},{"issue":"3","key":"10.1016\/j.phymed.2026.158584_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.phymed.2026.158584_bib0003","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/15384101.2022.2042777","article-title":"Molecular mechanisms for ABCA1-mediated cholesterol efflux","volume":"21","author":"Chen","year":"2022","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.phymed.2026.158584_bib0004","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamainternmed.2025.0115","article-title":"Statin use and risk of hepatocellular carcinoma and liver fibrosis in chronic liver disease","volume":"185","author":"Choi","year":"2025","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01591-1","article-title":"ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK\/ZEB1 pathway","volume":"39","author":"Cui","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0006","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.phymed.2026.158584_bib0007","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0008","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phymed.2026.158584_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116294","article-title":"Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8 (+) effector T cells in hepatocellular carcinoma","volume":"225","author":"Gao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158584_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157307","article-title":"Dihydroartemisinin inhibits histone lactylation through YAP1 to act as a 'hot' switch for 'cold' tumor in hepatocellular carcinoma","volume":"148","author":"Gao","year":"2025","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.phymed.2026.158584_bib0011","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","article-title":"Biomarkers for immunotherapy of hepatocellular carcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.11.034","article-title":"Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity","volume":"189","author":"Gu","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158584_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153913","article-title":"Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma","volume":"96","author":"Hao","year":"2022","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.phymed.2026.158584_bib0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2019.04.021","article-title":"Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma","volume":"71","author":"Jouve","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158584_bib0016","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5483\/BMBRep.2018.51.3.015","article-title":"DNA binding partners of YAP\/TAZ","volume":"51","author":"Kim","year":"2018","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI88486","article-title":"Hippo signaling interactions with wnt\/\u03b2-catenin and Notch signaling repress liver tumorigenesis","volume":"127","author":"Kim","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","article-title":"Interplay between YAP\/TAZ and metabolism","volume":"28","author":"Koo","year":"2018","journal-title":"Cell Metab."},{"issue":"6621","key":"10.1016\/j.phymed.2026.158584_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg3679","article-title":"Hippo signaling instructs ectopic but not normal organ growth","volume":"378","author":"Kowalczyk","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.phymed.2026.158584_bib0020","doi-asserted-by":"crossref","first-page":"1579054","DOI":"10.3389\/fonc.2025.1579054","article-title":"Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications","volume":"15","author":"Lagunas-Rangel","year":"2025","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0021","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cac2.12251","article-title":"Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials","volume":"42","author":"Lee","year":"2022","journal-title":"Cancer Commun. (Lond)"},{"issue":"22","key":"10.1016\/j.phymed.2026.158584_bib0022","doi-asserted-by":"crossref","first-page":"12723","DOI":"10.1093\/nar\/gkac1063","article-title":"TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism","volume":"50","author":"Li","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2026.158584_bib0023","article-title":"CSN6-SPOP-HMGCS1 axis promotes hepatocellular carcinoma progression via YAP1 activation","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"10","key":"10.1016\/j.phymed.2026.158584_bib0024","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/2326-6066.CIR-22-0907","article-title":"Cholesterol efflux drives the generation of immunosuppressive macrophages to promote the progression of Human hepatocellular carcinoma","volume":"11","author":"Li","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.phymed.2026.158584_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0026","first-page":"335","article-title":"Cholesterol metabolism and tumor immunity]","volume":"53","author":"Luo","year":"2022","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8 (+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158584_bib0028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2021.03.005","article-title":"YAP1\/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation","volume":"156","author":"Osman","year":"2021","journal-title":"J. Mol. Cell Cardiol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158584_bib0029","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1194\/jlr.R084244","article-title":"Thematic Review Series: lipid transfer proteins ABCG5 and ABCG8: more than a defense against xenosterols","volume":"59","author":"Patel","year":"2018","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.phymed.2026.158584_bib0030","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/ptr.7695","article-title":"Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy","volume":"37","author":"Peng","year":"2023","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0031","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2018.07.019","article-title":"Statins: old drugs as new therapy for liver diseases?","volume":"70","author":"Pose","year":"2019","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158584_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012345","article-title":"Targeting SQLE-mediated cholesterol metabolism to enhance CD8 (+) T cell activation and immunotherapy efficacy in hepatocellular carcinoma","volume":"13","author":"Qiao","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phymed.2026.158584_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151854","article-title":"Exploring combinations of dihydroartemisinin for cancer therapy: a comprehensive review","volume":"765","author":"Rani","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.phymed.2026.158584_bib0034","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s11010-024-05106-w","article-title":"Cholesterol suppresses AMFR-mediated PDL1 ubiquitination and degradation in HCC","volume":"480","author":"Shao","year":"2025","journal-title":"Mol. Cell Biochem."},{"issue":"12","key":"10.1016\/j.phymed.2026.158584_bib0035","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.phymed.2026.158584_bib0036","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110483118","article-title":"Molecular basis of cholesterol efflux via ABCG subfamily transporters","volume":"118","author":"Sun","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.phymed.2026.158584_bib0037","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","article-title":"Liver cancer in 2021: global Burden of Disease study","volume":"82","author":"Tan","year":"2025","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158584_bib0038","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.20222","article-title":"Association of Statin use with risk of liver disease, hepatocellular carcinoma, and liver-related mortality","volume":"6","author":"Vell","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.phymed.2026.158584_bib0039","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-981-15-6082-8_8","article-title":"Recent advances in the critical role of the sterol efflux transporters ABCG5\/G8 in health and disease","volume":"1276","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1016\/j.phymed.2026.158584_bib0040","article-title":"Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158584_bib0041","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1194\/jlr.M054544","article-title":"Relative roles of ABCG5\/ABCG8 in liver and intestine","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"issue":"7922","key":"10.1016\/j.phymed.2026.158584_bib0042","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-022-05006-3","article-title":"Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158584_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217901","article-title":"PD-L1 delactylation-promoted nuclear translocation accelerates liver cancer growth through elevating SQLE transcription activity","volume":"630","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158584_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"7","key":"10.1016\/j.phymed.2026.158584_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70783","article-title":"The role of cholesterol metabolism and its regulation in tumor development","volume":"14","author":"Wu","year":"2025","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.phymed.2026.158584_bib0046","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0216001","article-title":"Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol","volume":"110","author":"Yu","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phymed.2026.158584_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15301-0","article-title":"YAP1\/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity","volume":"11","author":"Yuan","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phymed.2026.158584_bib0048","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phymed.2026.158584_bib0049","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1042\/BST20190130","article-title":"ABCG5\/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion","volume":"47","author":"Zein","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phymed.2026.158584_bib0050","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.2147\/OTT.S315998","article-title":"Cholesterol metabolism as a potential therapeutic target and a prognostic biomarker for cancer immunotherapy","volume":"14","author":"Zhang","year":"2021","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.phymed.2026.158584_bib0051","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11684-022-0978-2","article-title":"Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy","volume":"17","author":"Zhang","year":"2023","journal-title":"Front. Med."},{"issue":"25","key":"10.1016\/j.phymed.2026.158584_bib0052","first-page":"00279","article-title":"Cholesterol metabolism: a new checkpoint in cancer immunity","volume":"S1471-4914","author":"Zhao","year":"2025","journal-title":"Trends Mol Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158584_bib0053","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","article-title":"The hippo signaling pathway in development and disease","volume":"50","author":"Zheng","year":"2019","journal-title":"Dev. Cell"},{"issue":"11","key":"10.1016\/j.phymed.2026.158584_bib0054","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tcb.2019.08.005","article-title":"Information theory: new look at oncogenic signaling pathways","volume":"29","author":"Zieli\u0144ska","year":"2019","journal-title":"Trends Cell Biol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:49:42Z","timestamp":1785509382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326008159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0944711326008159"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158584","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin promotes ABCG5\/G8-mediated cholesterol efflux to potentiate anti-PD-1 therapy through YAP1-TEAD1 complex disruption in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158584"}}